Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients - Trial NCT06414044
Access comprehensive clinical trial information for NCT06414044 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Florence and is currently Recruiting. The study focuses on Migraine,Migraine With Aura,Migraine Without Aura,Chronic Migraine. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Florence
Timeline & Enrollment
N/A
May 09, 2024
Apr 01, 2026
Primary Outcome
Changes in migraine frequency after three months of treatment,50% Response after three months of treatment
Summary
The purpose of this prospective and multicentric study is to evaluate the effectiveness and
 tolerability of atogepant as preventive migraine treatment in a cohort of episodic or chronic
 migraine patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06414044
Non-Device Trial